Search

Displaying results 6241 - 6250 of 8696 in total
  1. Drug

    Sumatriptan

    go.drugbank.com/drugs/DB00669
    ApprovedInvestigational

    Sumatriptan is a serotonin receptor agonist commonly used to treat migraines and sometimes cluster headaches.

    Categories: P-glycoprotein substrates, Serotonin Receptor Agonists
  2. Drug

    Solanezumab

    go.drugbank.com/drugs/DB11756
    Investigational

    Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.

  3. Drug

    NXC680

    go.drugbank.com/drugs/DB18366
    Experimental

    NXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF).

  4. Drug

    FLX475

    go.drugbank.com/drugs/DB15570
    Investigational

    FLX475 is a small molecule CCR4 antagonist being investigated for the treatment of cancer.[L9875]

  5. Drug

    Glucagon-like peptide II

    go.drugbank.com/drugs/DB12788
    Investigational

    Glucagon-like peptide II is under investigation for the basic science of Short Bowel Syndrome.

  6. Drug

    Urocortin-2

    go.drugbank.com/drugs/DB13033
    Investigational

    Urocortin 2 has been investigated for the basic science of Heart Failure and Cardiovascular Disease.

  7. Drug

    Pimonidazole

    go.drugbank.com/drugs/DB12485
    Investigational

    Pimonidazole is under investigation for the diagnostic of Prostate Cancer and Head and Neck Cancer.

  8. Drug

    Talaporfin

    go.drugbank.com/drugs/DB11812
    Investigational

    Talaporfin has been investigated for the treatment of Port-Wine Stain and Benign Prostatic Hyperplasia.

  9. Drug

    EXT608

    go.drugbank.com/drugs/DB18453
    Investigational

    EXT608 is a long-acting PTH derivative under investigation for the treatment of hyperparathyroidism.[L48270]

  10. Drug

    MUL001

    go.drugbank.com/drugs/DB18534
    Experimental

    MUL001 is live attenuated strain of _Salmonella typhimurium_ being investigated for the treatment of schwannomas.